Virologic Failure
Comparison of Three Different FDA Approved Plasma HIV 1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity
8
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV infected children in Tanzania: a four year follow up
9
A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen
9
Antiviral Resistance and Correlates of Virologic Failure in the first Cohort of HIV Infected Children Gaining Access to Structured Antiretroviral Therapy in Lima, Peru: A Cross Sectional Analysis
12
Prevalence and Factors Associated with Virologic Failure among People Living with HIV (PLHIV) Monitored in a Decentralized Health Care Facility
12
Virologic failure in HIV-positive adolescents with perfect adherence in Uganda: a cross-sectional study
10
Impact of peer support on virologic failure in HIV infected patients on antiretroviral therapy a cluster randomized controlled trial in Vietnam
14
Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control study
5
Immune correlates of CD4 decline in HIV infected patients experiencing virologic failure before undergoing treatment interruption
7
Rates of switching to second line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV infected adults with virologic failure in Rakai, Uganda
10
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
11
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
6
Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV 1 reverse transcriptase after the first virologic failure
11
Pre-Antiretroviral Therapy Serum Selenium Concentrations Predict WHO Stages 3, 4 or Death but not Virologic Failure Post-Antiretroviral Therapy.
18
Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional study
7
Original Article HIV drug resistance and related factors in patients receiving second-line combination antiretroviral therapy in rural China
6
Deep Sequencing Reveals Minor Protease Resistance Mutations in Patients Failing a Protease Inhibitor Regimen
7
Effectiveness_of_integrase_strand_transfer.8.pdf
9
Profile of etravirine in the treatment of HIV in pediatrics
9
Dolutegravir plus lamivudine as simplification dual therapy in virologically suppressed HIV-1 infected subjects
5